Two Molecular Forms of Adrenomedullin in Congenital Heart Disease
Ken Watanabe(Yamagata University), Shigeyuki Echigo(National Cerebral and Cardiovascular Center), Motoki Takamuro(National Cerebral and Cardiovascular Center), Hirofumi Matsuoka(Dokkyo University), Kenji Kangawa(National Cerebral and Cardiovascular Center), Kenji Yasuda(National Cerebral and Cardiovascular Center), Osamu Yamada(JR Tokyo General Hospital), Saori Tanabe(National Cerebral and Cardiovascular Center), Toshio Nishikimi(Kyoto University), N Nagaya(National Cerebral and Cardiovascular Center), Yuichi Ishikawa(Japanese Circulation Society)
Cited by 4
Related Papers
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension
|Journal of the American College of Cardiology|1998|578
The role of natriuretic peptides in cardioprotection
|Cardiovascular Research|2005|483
Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.
|Journal of Clinical Investigation|1994|478
Increased plasma levels of adrenomedullin in patients with heart failure
|Journal of the American College of Cardiology|1995|307